Kempen acted as Sole Financial Adviser in the sale of Medsen and Ceban
Transaction highlights
Kempen advised the shareholders of AIO II on its sale to funds under management by Bencis, a private equity firm investing in mid-sized companies in the Benelux and Germany
After a robust development over the last decade, majority owner Van Lanschot Kempen decided earlier this year to sell its non-strategic stake which was acquired in a debt-for-equity swap in 2009
Transaction is expected to be completed early 2019 and is subject to approval by the relevant (competition) authorities
Company description
AIO II is the holding company of Medsen Pharmacies, which is one of the largest independent pharmacy chains in the Netherlands, the central compounding pharmacy Ceban and the provider of dispensing machines Pharma Robots
The group recorded a turnover of EUR 92.3m in 2017 and is headquartered in Breda, the Netherlands